(Q37065131)

18 August 2017

1 reference

title

Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema (English)

1 reference

18 August 2017

main subject

hereditary angioedema

1 reference

Aleena Banerji

1

1 reference

18 August 2017

David E Sloane

series ordinal

2

1 reference

18 August 2017

Albert L Sheffer

series ordinal

3

1 reference

18 August 2017

publication date

1 January 2008

1 reference

Annals of Allergy, Asthma & Immunology

18 August 2017

published in

1 reference

18 August 2017

volume

100

1 reference

18 August 2017

issue

1 Suppl 2

1 reference

18 August 2017

page(s)

S19-22

1 reference

Current and future therapy for hereditary angioedema.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Regulation of C1 inhibitor synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Hereditary angioedema: a broad review for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Hereditary angioedema: the clinical syndrome and its management in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Methyltestosterone Therapy in Hereditary Angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Management of hereditary angio-oedema with low-dose danazol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Long-term therapy of hereditary angioedema with danazol.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

The long-term safety of danazol in women with hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

The effects of fetal exposure to danazol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Remission of pure red cell aplasia following oxymetholone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

A familial case of hereditary angioneurotic edema in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

A case of cryofibrinogenaemia responsive to stanozolol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Effect of anabolic steroids on HIV-related wasting myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Clinical and biochemical effects of stanozolol therapy for hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Hereditary angioedema: a decade of management with stanozolol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Hereditary angioedema: Safety of long-term stanozolol therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Clinical management of hereditary angio-oedema in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Hereditary angio-oedema: treatment with danazol. Report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

Oxandrolone treatment of childhood hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960582-0

7 January 2021

10.1016/S1081-1206(10)60582-0

Identifiers

DOI

1 reference

18 August 2017

1 reference